| For: | Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A, Yang J. Insights into renal and urological complications of inflammatory bowel disease. World J Nephrol 2024; 13(3): 96574 [PMID: 39351187 DOI: 10.5527/wjn.v13.i3.96574] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i3/96574.htm |
| Number | Citing Articles |
| 1 |
Maja Ban, Hana Matković, Mirna Natalija Aničić, Marijana Ćorić, Zoltán Prohászka, Lovro Lamot. C3 glomerulopathy associated with anti-factor H autoantibodies in a child with inflammatory bowel disease. Pediatric Nephrology 2026; doi: 10.1007/s00467-026-07415-2
|
| 2 |
Dinesh Thapa, Anjali Ghimire, Leon N. Warne, Rodrigo Carlessi. Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease. Pharmaceuticals 2025; 18(4) doi: 10.3390/ph18040478
|
| 3 |
Melanie Breit, Jochen Klaus. Risiken und Nebenwirkungen von Immunsuppressiva in der Therapie chronisch entzündlicher Darmerkrankungen. Gastroenterologie up2date 2026; 22(02) doi: 10.1055/a-1354-3478
|
| 4 |
茜 罗. Research Progress on the Relationship between Inflammatory Bowel Disease and Kidney Diseases. Advances in Clinical Medicine 2025; 15(01) doi: 10.12677/acm.2025.151297
|
| 5 |
Ana Isabel Balbuena, Noelia Poveda, Araceli López, María José Ferri. Papel del laboratorio clínico en el estudio de nefrolitiasis y cristaluria por mesalazina. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2025; 6(4) doi: 10.1515/almed-2025-0094
|
| 6 |
Antonio M. Caballero-Mateos, Eduard Brunet-Mas, Beatriz Gros. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine 2025; 14(22) doi: 10.3390/jcm14227984
|
| 7 |
Giovanna Fernanda Vazzana, Alessia Romano, Chiara Casuscelli, Alberto La Spada, Domenico Santoro, Roberto Chimenz, Claudio Romano. A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease. Clinical Case Reports 2026; 14(4) doi: 10.1002/ccr3.72418
|
| 8 |
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease. World Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825
|
| 9 |
Ana Isabel Balbuena, Noelia Poveda, Araceli López, María José Ferri. The role of the clinical laboratory in the study of mesalazine-induced nephrolithiasis and crystalluria. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2025; 6(4) doi: 10.1515/almed-2025-0164
|